H
HyperVigilant develops AI-driven technology to improve the identification and management of hypertension and cardio-metabolic diseases. The company offers ANDI, an AI chatbot providing accessible, culturally sensitive health information and lifestyle guidance. This platform supports earlier intervention and better health outcomes, particularly for underserved populations.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- HyperVigilant develops AI-driven technology to improve the identification and management of hypertension and cardio-metabolic diseases. The company offers ANDI, an AI chatbot providing accessible, culturally sensitive health information and lifestyle guidance. This platform supports earlier intervention and better health outcomes, particularly for underserved populations.